Introduction
In the wake of an exponential global rise in diabetes, extensive studies have been performed regarding diabetes pathology. However, the mechanisms responsible for blood glucose regulation, which is key in diabetes treatment, have not been fully elucidated as yet. In particular, the complete molecular mechanisms underlying cellular glucose uptake and clearance in diabetes remain obscure. Characterization of these molecular events has been impaired due, in part, to the scarcity of reliable methodologies that can directly monitor glucose dynamics within living cells. Currently, monitoring intracellular glucose dynamics largely relies on nuclear magnetic resonance spectroscopy and inferring glucose uptake from complex glucose clamp and tracer infusion techniques, which indirectly measure intracellular glucose levels. [1] [2] [3] [4] Another technique, positron emission tomography, is routinely used to estimate glucose metabolism in localized tissue regions, but it does not provide estimates of intracellular glucose dynamics. 5, 6 Many approaches have been tested to circumvent these problems. One in particular, fluorescence resonance energy transfer (FRET), has been applied for developing a number of fluorescent sensor proteins that can be used to monitor blood glucose. 7 These sensor proteins, or glucose indicator proteins (GIPs), can be expressed inside the cells to visualize glucose dynamics through FRET-imaging microscopy measurements. [8] [9] [10] In a FRET glucose sensor protein, enhanced cyan fluorescent protein (ECFP) and enhanced yellow fluorescent protein (EYFP) are linked by a glucose-binding protein (GBP). 11, 12 When glucose binds to the GBP, it triggers rearrangement of the flap region located on one side of the hinge β-sheet, leading to an alteration in the distance between the ECFP and EYFP and thus generating a FRET signal that can be used for glucose measurement. 7, 11, 12 In essence, these proteins can be used to determine intracellular glucose levels through FRET microscopy measurement, 8, 13, 14 a technique that has been adapted for studying glucose uptake and clearance in a variety of cells under various conditions, offering new insights into glucose metabolism in cells.
However, while FRET intensity-based imaging microscopy measurement is useful for end-point analysis, it is not suitable for the continuous monitoring of glucose dynamics within living cells because of the photobleaching of ECFP and EYFP during repeated exposures for microscopic imaging measurements. For instance, because ECFP is prone to excessive photobleaching, the FRET signal reduces significantly during measurement. 15 Overall, photobleaching and crosstalk between the ECFP and the EYFP-caused by their largely overlapping excitation and emission spectrawarrant elaborate estimations of correction factors. 16, 17 Fluorescence lifetime imaging microscopy (FLIM) measurement offers a complementary method to intensity-based FRET analysis. In FLIM, changes in FRET efficiency can be determined by measuring changes in the lifetime of a donor. This lifetime is independent of probe concentration but depends on the chemical and physical properties of the local environment, including the energy transfer from a donor to its acceptor in FRET. 18, 19 Because only the donor's lifetime is monitored, the crosstalk between a donor and its acceptor, such as that between ECFP and EYFP, does not affect the lifetime measurement. 20 This FLIM approach has been validated by the spectral imaging of similar GFP molecules and interactions between protein and deoxyribonucleic acid (DNA) in living cells. 21, 22 There are two ways to perform FLIM: time-domain FLIM (TD-FLIM) and frequency-domain FLIM (FD-FLIM). [21] [22] [23] Time-domain-FLIM is extremely slow to implement and cannot achieve the short acquisition time required for visualizing the dynamics of intracellular molecules. On the other hand, in FD-FLIM, fluorescence lifetime is determined by measuring the phase shift and amplitude reduction of the fluorescence using a detector equipped with a gain modulator. Compared with TD-FLIM, FD-FLIM is simpler and much more cost-effective because it uses a sinusoidally modulated light-emitting diode (LED) light source for nanosecond (ns) measurements. In addition, FD-FLIM has been used in quantitative pH imaging conducted on a FRET sensor protein developed by Esposito and coauthors. 24 Despite such advances in FD-FLIM, using a fluorescent sensor protein for imaging the dynamics of intracellular glucose, has yet to be realized, to the best of our knowledge. In this work, we adopted FD-FLIM to investigate the feasibility of applying this technique for real-time determination of intracellular glucose dynamics within living cells using a FRET glucose probe. The work presented herein offers a new CGM molecular sensor platform.
Methods

GIP Construction
The construction of a GIP has been described previously; 10 however, in brief, the sensor protein was constructed by attaching Aequorea coerulescens green fluorescent protein (AcGFP1) and a red fluorescent protein (mCherry) to the N-and C-termini of a mutant GBP (GBPcys). 7, 11, 12 The resultant plasmid is referred to as pTA-AcGFP1-GBPcys-mCherry. To express GIPs in mammalian cells, the AcGFP1-GBPcys-mCherry fusion gene was subcloned to pcDNA3.1 plasmid (Life Technologies Corporation, Carlsbad, CA).
Ratiometric FRET Imaging Microscopy Measurement
Murine myoblast cells, C2C12 (ATCC ® CRL-1772 ™ ), were routinely maintained at 37 o C and 5% CO 2 in Dulbecco's Modified Eagles's Medium (Mediatech, Inc., Manassas, VA). For imaging, cells were seeded onto 40 mm circular glass cover slips. To express GIPs, plasmid pcDNA3.1AcGFP1-GBPcys-mCherry was transiently transfected into C2C12 cells when they were 50-60% confluent, using Polyfect Transfection Reagent (QIAGEN Inc., Valencia, CA). Imaging was performed at 24-48 h post-transfection using an inverted fluorescence microscope (Olympus IX71, ® Japan), described in detail elsewhere. 10
Frequency-Domain FLIM
The FD-FLIM System (LIFA, Lambert Instruments, The Netherlands) consists of a signal generator, a 3-W LED as the excitation source, and an intensified charge-coupled device (CCD) (LI²CAM, Lambert Instruments) equipped with a multichannel plate (MCP)-based image intensifier. Both the LED and signal generator are computer controlled using LI-FLIM 1.2.7 software (Lambert Instruments). The intensified CCD camera was mounted onto an inverted phase contrast fluorescence microscope (Olympus IX51, ® Japan). A schematic diagram of the FD-FLIM system is illustrated in Figure 1 . The lifetime of the AcGFP1 was detected by means of the LED light source (485 nm), a filter cube entailing a 470/40-nm band-pass excitation filter, a 495LP dichroic mirror, and a 525/50-nm band-pass emission filter (Chroma Technology Corporation, Vermont). The ECFP was detected with use of the LED (445 nm), a filter cube encompassing a 436/20-nm band-pass excitation filter, a 455LP dichroic mirror, and a 480/40-nm band-pass emission filter (Chroma Technology Corporation). To perform FD-FLIM, the excitation light from the LED was modulated in intensity at a frequency of 1-100 MHz, leading to the intensity modulation of its induced fluorescence. Due to the decay of the light emission, the fluorescence exhibited a phase shift (delay in time) and a decrease in modulation depth with respect to the excitation light. 25 This phase shift and decrease in modulation depth depended on the decay constants of a fluorophore. To extract the phase shift and the decrease in modulation depth from the emission signal relative to the excitation signal, the sensitivity of the image intensifier was modulated at the same frequency. Signals were detected at each phase step during a short integration period of the CCD camera. When emission signals were in phase with the Veetil www.journalofdst.org J Diabetes Sci Technol Vol 6, Issue 6, November 2012 sensitivity of the intensifier, a high detector signal level was measured. Likewise, when emission signals were out of phase with the sensitivity of the intensifier, a low detector signal level was measured. A sine function was fitted to the intensity-versus-phase-delay data, pixel by pixel. Lifetime values were extracted from the phase delay in fluorescence and the modulation of emission compared with excitation, and these values were used to determine changes in the lifetime of the sensor protein in response to variation in intracellular glucose.
Live-Cell Time-Lapse FLIM
To perform live-cell time-lapse FLIM, GIP-expressing C2C12 cells were grown on cover slips in a gas-tight, temperature-controlled perfusion chamber (Model FCS2 ® , Bioptechs Inc., Butler, PA). A medium containing various concentrations of glucose was perfused through the chamber at a flow rate of 1.0-1.5 ml/min using a gravityfed six-way perfusion device (Warner Instruments, Hamden, CT) controlled by a Cheminert ® multiposition valve with a microelectric actuator (VICI ® Valco Instruments, Houston, TX) and a flow regulator (Warner Instruments, Hamden, CT) ( Figure 1B) . The perfusion solution (pH = 7.2) was composed of 140 mM sodium chloride, 5 mM potassium chloride, 1.1 mM magnesium chloride, 2.5 mM calcium chloride, and 10 mM 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid (also known as HEPES) supplemented with either 10 mM glucose or 10 mM N-methyl-d-glucamine (NMDG), a glucose analog. The height as well as the volume of the chamber was fixed with a 0.5-mm-thick gasket.
Fluorescence lifetime was measured by modulating the LED excitation light and the detector-intensifier gain at a frequency of 40 MHz. Each experiment was completely recorded with an image stack that includes both the reference phase stack and the sample phase stack. An image stack of the reference or sample phase stack is a series of 12 images recorded at 12 different phases at the same modulation frequency. Generally, 12 images were captured at phase intervals of 30 0 with a random order and a background image (without excitation). Twelve images were selected to ensure a good compromise between the speed and accuracy of the measurement. The fluorescence lifetime for a single pixel was calculated by recording the phase shift and the decrease in modulation depth of the fluorescence light emitted by the sample. By recording a reference, the software identified the phase of the system (i.e., entire setup) and the modulation for a lifetime of t = 0 ns. Every deviation in phase and modulation of emitted fluorescence from the sample corresponded to a certain lifetime. An ideal reference is a material or solution with a uniformly distributed concentration of fluorescent molecules and a single lifetime component that can be used with the same filter cube as that of the sample. In this study, a fluorescein solution with a known lifetime was used to record a reference phase stack. A 10 µm amount of fluorescein (Sigma-Aldrich, St. Louis, MO) dissolved in 100 mM of Tris(hydroxymethyl)aminomethane (Tris) buffer (pH 10) with a known single lifetime of 4.00 ns served as the reference fluorophore for calibration. This value was used to deduce the system modulation and phase for a lifetime of 0.0 ns. A Tris buffer was used to further dilute the fluorescein to the appropriate concentration. To obtain the most accurate lifetime measurements, it is best to maintain the intensifier-gain and exposure-time settings at the same level or within a very close range between a reference recording and a sample recording. As a result, the sample fluorescence image recordings are optimized and completed before reference lifetime images are recorded. By changing the concentration of the fluorescein solution, we easily matched the exposure time and MCP voltage between the sample and the reference.
A 16-bit, 2 × 2 binned mode was used for all measurements because 16 bits offer the best intensity resolution supported by the LI 2 CAM. This camera has actually a 12-bit resolution that is stretched to 16 bits. The 2 × 2 binning could decrease the spatial resolution and increase the sensitivity of the measurement. The 2 × 2 binning of a 1.4-megapixel chip is usually not the limiting factor for spatial resolution. The image intensifier usually determines its maximum resolution when used for FLIM imaging. We set the gain for the camera at 1. Camera exposure time and MCP voltage were adjusted for different samples according to the manufacturers' instructions. The exposure time ranged from 100 ms to 400 ms, depending on the level of expression of the sensor protein at MCP voltage 400-600 V. Background correction was performed automatically by subtracting an image obtained with blocked excitation, but, otherwise, the settings used were identical with the sample settings.
Results
Lifetimes of the ECFP and AcGFP1 were determined in the C2C12 cells (Figure 2) . The lifetime of the ECFP determined from phase shifting was 2.3 ns, whereas its modulation lifetime was 3.0 ns, with the valid pixelvalue of the region of interest (ROI) = 677. Differences in the calculated lifetimes indicated that the ECFP exhibited a multiexponential decay in C2C12 cells. 26 By contrast, the AcGFP1 donor exhibited monoexponential decay.
The normalized count (count in a class divided by total number of observations; in this case relative counts were normalized to sum one) curve of the phase shift overlapped with its normalized count curve of modulation change, indicating a single exponential lifetime of 2.70 ns, with the valid pixel-value of the ROI = 1217 (Figure 2C) .
FLIM imaging of AcGFP1-GBPcys-mCherry or AcGFP1-GBPcys-expressing cells was performed at 48 h posttransfection in the absence of extracellular glucose (Figure 3) . The lifetime of AcGFP1 detected from AcGFP1-GBPcys-expressing cells was 2.70 ns whereas the lifetime decreased to 2.10 ns in AcGFP1-GBPcys-mCherry-expressing cells. A FRET efficiency of 22% was estimated for this biosensor based in the equation:
where t a is the lifetime of AcGFP1 determined from AcGFP1-GBPcys-mCherry-expressing cells, and t m is the lifetime of AcGFP1 measured from AcGFP1-GBPcysexpressing cells. Based on the value of E, separation distance was estimated between AcGFP1 from mCherry in the AcGFP1-GBPcys-mCherry sensor protein without glucose binding. Because R 0 (Förster distance) depends on the spectral properties of both donor and acceptor, 27 it can be given that:
where J is the spectral overlap integral, q D is the donor fluorescence quantum yield, n is the refractive index of the medium (assumed to be 1.3 for the calculation), 28 κ 2 is the orientation factor (assumed to be 0.667 corresponding to the random donor and acceptor orientation). 29 J (nm 4 M -1 cm -1 ) can be determined as follows:
where ε A (λ) is the (wavelength-dependent) extinction coefficient of the acceptor (M -1 cm -1 ), f D (λ) is the (wavelength-dependent) donor fluorescence intensity (arbitrary units), and λ is the wavelength (nm). The q D of 0.82 for AcGFP1 and the maximal extinction coefficient of the acceptor ε A of 72,000 M -1 cm -1 30 were adopted to scale the measured mCherry absorbance spectrum to obtain ε A (λ). FRETView software 31-33 was adopted to deduce the R 0 of the AcGFP-mCherry pair to be 55.9 Å. On the other hand,
where R is the distance between the donor and acceptor. By substituting both E and R 0 values into Equation (4), we estimated the R value; i.e., in the absence of glucose binding, the AcGFP1 was separated from mCherry at a distance of approximately 68.9 Ǻ. When glucose was bound to the protein, the donor lifetime increased to 2.26 ns, corresponding to a 72.8-Ǻ separation between fluorophores.
Next, we examined the effect of photobleaching on continuous FD-FLIM. We carried out a time-lapse lifetime imaging of C2C12 cells expressing AcGFP1-GBPcys protein. Both fluorescent intensity and lifetime of AcGFP1 were measured every 12 s for 1000 s. The bath solution containing either 10 mM glucose or 10 mM NMDG was perfused into the cell culture chamber, as shown in Figure 4 . The fluorescence intensity of AcGFP1 dropped 12% continuously during imaging (Figure 4) . By contrast, the lifetime of AcGFP1 remained stable during imaging, suggesting the superiority of lifetime imaging over intensity imaging for quantifying the dynamics of intracellular molecules.
After confirming stability of FLIM detection, we quantified the dynamics of cellular glucose uptake and clearance in response to variation in extracellular glucose using FLIM. The AcGFP1-GBPcys-mCherry sensor protein was transiently transfected into C2C12 cells. A bath solution containing either 10 mM glucose or 10 mM NMDG was flown into the cell culture chamber, and changes in intracellular glucose concentrations were continuously monitored by measuring changes in the lifetime of AcGFP1 (Figure 5A) . The cellular glucose uptake and clearance rates in response to variation in extracellular glucose concentration were determined by fitting lifetime measurements with first-order exponential regression (Figures 5B and 5C) . The lifetime of AcGFP1 was observed to rise with the increase in intracellular glucose concentration, indicating glucose uptake. By contrast, the lifetime dropped after removal of the extracellular glucose when perfusing NMDG. Glucose uptake (rate constant at 45 s) also appeared to be faster than its clearance (rate constant at 88 s).
Finally, we determined whether there was any glucose concentration gradient within the living cells. Compared to intensity-based FRET, the FD-FLIM detected the spatial distribution of molecules with much higher resolution. 18, 34 Both intensity and lifetime FRET imaging microscopy measurement were performed on cells expressing the AcGFP1-GBPcys-mCherry sensor protein in the presence of 10 mM glucose. Two ROIs, i.e., a region close to the cell membrane and a region close to the nucleus, were selected in a single cell (Figures 6A and 6C) . By plotting fluorescence intensity of AcGFP1 vs each pixel in these two regions, we observed no difference in the pattern of intensity distribution between these two regions ( Figure 6B) . The lifetime of AcGFP1 determined in ROI1 (395 pixels), i.e., a region close to the cell membrane was 2.34 ns, whereas the lifetime of AcGFP1 in ROI2 (338 pixels), i.e., a region close to the nucleus, was 2.12 ns (Figure 6D) , indicating a low glucose concentration in the area close to the nucleus. It was manifest that glucose uptake occurred in the interface between the cell and the cell-culture medium; thus, an elevated concentration of glucose as opposed to the ROI close to the nucleus. However, the FRET intensity imaging microscopy measurement failed to reveal this difference (Figure 6B) . 
Discussion
Thus far, intracellular glucose monitoring has relied on radioisotope-labeled glucose analogs and fluorescenceintensity imaging. Measurement that depend on isotopic analogs do not reveal the dynamics of glucose uptake and clearance in living cells, 2 whereas fluorescence intensity-imaging methods are affected by issues such as photobleaching. 18 Although a number of GFP-based glucose sensor proteins have been developed, 7, 9, 11 the application of these sensor proteins for continuous glucose monitoring within living cells has been limited. The most widely employed fluorophore, ECFP, is known to exhibit light-induced variations in its lifetime that are not proportional to decreases in steady-state fluorescence intensities and that vary from cell to cell. 35 Furthermore, a concentration-dependent quenching of ECFP in the absence and presence of EYFP significantly diminishes the accuracy of the detection using ECFP/EYFP. 36, 37 These drawbacks can be overcome by choosing fluorescence proteins that are more tolerant to photobleaching. Here, we investigated the feasibility of pairing AcGFP1 with mCherry for FD-FLIM and then successfully demonstrated, for the first time, that FD-FLIM of the AcGFP1-GBPcys-mCherry sensor protein monitored changes in intracellular glucose concentrations in response to variations in extracellular glucose levels. In essence, the fluorescent sensor protein developed herein allowed for the determination of glucose uptake and clearance rate through FD-FLIM. To minimize the effect of photobleaching on the lifetime of the AcGFP1-GBPcys-mCherry glucose sensor, we adopted a random 12-phase image acquisition approach. 38 With this approach we observed that the lifetime of AcGFP1 remained stable during time-lapse FRET imaging. This result is consistent with the work of others 35 and is significant because the visualization of intracellular molecular events has long been limited to intensity-based FRET imaging microscopy and TD-FLIM. FD-FLIM is, in fact, a better approach than TD-FLIM because although TD-FLIM [particularly time-correlated single-photon counting (TCSPC)] can provide a very high resolution in a wide-field setup, additional signal processing is needed to obtain the position of a photon. If a special detector is used with TCSPC, it would also require a photocathode, a MCP, and a delay-line system or a four-element anode system at the output. TD-FLIM offers high counting efficiency and good temporal resolution. However, the system makes it difficult to reach a high count rate and also requires complex detectors that are not widely available. [39] [40] [41] [42] Another finding in this study is that, compared to the multiexponential decay of ECFP, 43 AcGFP1 exhibits only monoexponential decay, which makes it suitable for continuous intracellular glucose monitoring through FD-FLIM (Figure 3) . The dissociation constant of the sensor protein for glucose was estimated to be 0.13 mM, 10 making it suitable for use in monitoring intracellular glucose concentrations because the mean intracellular glucose concentration is approximately 0.10-0.20 mM in both healthy humans and those with diabetes. 3 We have also found that FRET-FLIM is less affected by light scattering and the local concentration of sensor proteins, 38, [44] [45] [46] [47] making it ideal for three-dimensional (3D) imaging. Such 3D imaging can be achieved using a spinning-disk confocal microscope where samples are scanned simultaneously by thousands of pinholes, resulting in a virtually instantaneous image with more than a 10-fold reduction in photobleaching. 48, 49 The integration of a spinning-disk unit into a frequency-domain FLIM instrument could reduce artifacts considerably while maintaining the advantages of a wide field, especially for FLIM on objects with a 3D lifetime structure. 50, 51 Realization of this measurement would potentially allow for the continuous monitoring of intracellular cellular glucose concentrations in animal models, offering a new tool for studying the pathology of diabetes.
Conclusions
We demonstrated the feasibility of using FD-FLIM to monitor the dynamics of intracellular glucose concentration changes in response to extracellular glucose concentrations. Our experimental results revealed that glucose uptake by the C2C12 cells was relatively faster than its clearance. Our results are in agreement with the observations made by other groups using timelapse intensity measurements in live cells. 8, 13 This sensor could potentially be used for both in vitro and in vivo continuous glucose monitoring. Intracellular glucose monitoring under various pathophysiological conditions in different cells and tissues could accelerate the research on drug discovery and diabetes treatment. The FD-FLIM developed herein can be combined with the spinningdisk confocal unit for 3D FD-FLIM imaging of intracellular glucose concentrations in animal models.
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